Drug Type Synthetic peptide |
Synonyms- |
Target- |
Action modulators |
Mechanism Cell membrane modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | United States | 27 Dec 2022 | |
Gram-Negative Bacterial Infections | Preclinical | United States | 27 Dec 2022 | |
Gram-Positive Bacterial Infections | Preclinical | United States | 27 Dec 2022 | |
Gram-Positive Bacterial Infections | Preclinical | United States | 27 Dec 2022 |